Sunday, September 13, 2026
ExploreSearch
Via News
MarketCommodities

Palladium Futures Slides By 3% In The Last 10 Sessions

ViaNews Editorial Team

October 2, 2023

Palladium Futures Slides By 3% In The Last 10 Sessions

(VIANEWS) - Palladium (PA) has been up by 3.53% for the last 10 sessions. At 11:52 EST on Monday, 2 October, Palladium (PA) is $1,214.50.

Volume

Today's last reported volume for Palladium is 3905, 99.99% below its average volume of 4263962200.09.

Volatility

Palladium's last week, last month's, and last quarter's current intraday variation average was 0.95%, 0.65%, and 1.44%, respectively.

Palladium's highest amplitude of average volatility was 2.00% (last week), 1.28% (last month), and 1.44% (last quarter), respectively.

News about

  • Crude oil forecast: finds buyers on every dip - 02 October 2023. According to DailyForex on Monday, 2 October, "The WTI Crude Oil market had a robust trading session on Friday in the beginning, with buyers continuing to dominate. "

More news about Palladium (PA).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesPAPalladiumPrice DownCommodities Price DownCommodities Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com